Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Prasugrel Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101402556A reveals a low-toxic route for 1-cyclopropyl-2-(2-fluorophenyl)-2-hydroxyethanone. Enhance supply chain reliability and reduce manufacturing costs with this scalable method.
Novel synthesis of Prasugrel intermediate via alkylation and borylation. Offers high purity, reduced waste, and scalable manufacturing for global pharmaceutical supply chains.
Novel synthesis of 2-cyclopropyl-1-(2-fluorophenyl)-2-carbonyl ethyl p-toluenesulfonate via Weinreb amide. High yield, low cost, scalable process for API manufacturing.
Patent CN104418718A reveals a high-yield bromination route for prasugrel intermediates, offering cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN102241689A details a safe, high-yield route for prasugrel intermediates using metal salt oxidation, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Discover a novel, non-Grignard synthesis for 1-cyclopropyl-2-(2-fluorophenyl) ethyl ketone. Enhanced safety, mild conditions, and scalable manufacturing for antithrombotic APIs.
Patent CN102212070B details a one-pot synthesis for Prasugrel intermediates, offering high yield and mild conditions for cost reduction in pharmaceutical manufacturing.
Advanced HBr/H2O2 bromination route for high-purity prasugrel. Cost-effective, scalable manufacturing solution for global pharma supply chains.
Patent CN101888988A details a scalable halogenation method for 2-halo-1-cyclopropyl-2-substituted acetophenone, offering superior purity and cost efficiency for API manufacturing.
Advanced 3-step synthesis of Prasugrel intermediates via patent CN102030761A. Offers cost reduction in pharmaceutical intermediates manufacturing with high scalability.